Search
Amisulpride
go.drugbank.com/drugs/DB06288ApprovedInvestigationalIn the US, the intravenous formulation of amisulpride is used to treat and prevent postoperative nausea and vomiting in adults, either as monotherapy or in combination with another antiemetic agent of … [L32764] Amisulpride is also used as an antiemetic agent.
Synonyms: 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide, 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamideCategories: MATE 1 Inhibitors, MATE 1 SubstratesIron sucrose
go.drugbank.com/drugs/DB09146ApprovedInvestigationalDue to less side effects than iron dextran, iron sucrose is more preferred in chronic kidney disease patients. … Iron sucrose (sucroferric oxyhydroxide or iron saccharate) is used as a source of iron in patients with iron deficiency anemia with chronic kidney disease (CKD), including those who are undergoing dialysis
Mixtures: Myferon 150 ForteProducts: VELTIFER 100 MG/5 ML ORAL ÇÖZELTİ, 10 ADET, VELTIFER 100 MG/5 ML ORAL ÇÖZELTİ, 20 ADETBetahistine
go.drugbank.com/drugs/DB06698ApprovedInvestigationalIt is thought to reduce symptoms through its actions on histamine receptors. … It is currently marketed in Canada by various companies, including Teva Pharmaceuticals.
Synonyms: N-methyl-2-(2-pyridinyl)ethanamine, N-methyl-2-pyridineethanamineCategories: Heterocyclic Compounds, 1-RingPertuzumab
go.drugbank.com/drugs/DB06366ApprovedInvestigationalPertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). … It was first approved by the FDA in 2012 for use with [docetaxel] and another HER2-targeted monoclonal antibody, [trastuzumab], in the treatment of metastatic HER2-positive breast cancer.
Mixtures: PHESGO® 1200 MG/600 MG, PHESGO® 1200 MG/600 MGCategories: Receptor, ErbB-2, antagonists & inhibitors, HER2 (Human Epidermal Growth Factor Receptor 2) inhibitorsIsosorbide mononitrate
go.drugbank.com/drugs/DB01020ApprovedInvestigationalIsosorbide mononitrate is an organic nitrate with vasodilating properties. … [L11698, L11743] Isosorbide mononitrate is an active metabolite of [isosorbide dinitrate].
Synonyms: IS 5-MN, IS-5-MNCategories: Vasodilators Used in Cardiac DiseasesSertraline
go.drugbank.com/drugs/DB01104ApprovedInvestigationalDespite marked structural differences between compounds in this drug class, SSRIs exert similar pharmacological effects.
Synonyms: (1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine, (1S,4S)-sertralineProducts: ZOLOF CONCENTRADO ORAL 20 MG/ML, SERTRALINA EGMetformin
go.drugbank.com/drugs/DB00331ApprovedInvestigationalMetformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the management of type II diabetes. … [A36559] Metformin was first approved in Canada in 1972,[A36552] and received subsequent FDA approval in the US in 1995.[L12207]
Mixtures: VILMET 50 MG/1000 MG FILM KAPLI TABLET ,1TABLET, 20 ADET, XIGDUO XR (TABLETS 10 MG/1000 MG)Categories: MATE 1 Substrates, MATE 2 SubstratesAminophylline
go.drugbank.com/drugs/DB01223ApprovedInvestigationalAminophylline is a drug combination that contains theophylline and ethylenediamine in a 2:1 ratio. … The majority of aminophylline medications are discontinued and the remaining medications on the market are in short supply.
Categories: Heterocyclic Compounds, 2-Ring, Compounds used in a research, industrial, or household settingProducts: AMINOCARDOL 10 ML 240 MG 100 AMPUL, AMINOFILINA 240 MG / 10 ML.Vinorelbine
go.drugbank.com/drugs/DB00361ApprovedInvestigationalA study was done on the clearance rate of vinorelbine on individuals with various single polymorphonuclear mutations. … It was initially approved in the USA in 1990's for the treatment of NSCLC [L2010]. It is a third-generation vinca alkaloid.
Categories: Heterocyclic Compounds, 2-RingProducts: NAVELBINE 20 MG, NAVELBINE® 20 MGCephalexin
go.drugbank.com/drugs/DB00567ApprovedInvestigationalVet approved[A179083,L6547] Cephalexin was approved by the FDA on 4 January 1971.[L6547]
Synonyms: (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidCategories: Heterocyclic Compounds, 2-Ring, MATE 1 Substrates